Title |
IDH1 and IDH2 Mutations in Gliomas
|
---|---|
Published in |
Current Neurology and Neuroscience Reports, March 2013
|
DOI | 10.1007/s11910-013-0345-4 |
Pubmed ID | |
Authors |
Adam L. Cohen, Sheri L. Holmen, Howard Colman |
Abstract |
Mutations in isocitrate dehydrogenase (IDH) 1 and 2, originally discovered in 2008, occur in the vast majority of low-grade gliomas and secondary high-grade gliomas. These mutations, which occur early in gliomagenesis, change the function of the enzymes, causing them to produce 2-hydroxyglutarate, a possible oncometabolite, and to not produce NADPH. IDH mutations are oncogenic, although whether the mechanism is through alterations in hydroxylases, redox potential, cellular metabolism, or gene expression is not clear. The mutations also drive increased methylation in gliomas. Gliomas with mutated IDH1 and IDH2 have improved prognosis compared with gliomas with wild-type IDH. Mutated IDH can now be detected by immunohistochemistry and magnetic resonance spectroscopy. No drugs currently target mutated IDH, although this remains an area of active research. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 10% |
Saudi Arabia | 2 | 10% |
Colombia | 1 | 5% |
Venezuela, Bolivarian Republic of | 1 | 5% |
India | 1 | 5% |
Kuwait | 1 | 5% |
Turkey | 1 | 5% |
Brazil | 1 | 5% |
Canada | 1 | 5% |
Other | 0 | 0% |
Unknown | 9 | 45% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 12 | 60% |
Scientists | 4 | 20% |
Practitioners (doctors, other healthcare professionals) | 3 | 15% |
Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 8 | <1% |
United Kingdom | 5 | <1% |
Germany | 3 | <1% |
Brazil | 3 | <1% |
Portugal | 2 | <1% |
Italy | 1 | <1% |
Sweden | 1 | <1% |
South Africa | 1 | <1% |
Finland | 1 | <1% |
Other | 10 | <1% |
Unknown | 1193 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 196 | 16% |
Student > Master | 176 | 14% |
Researcher | 153 | 12% |
Student > Bachelor | 150 | 12% |
Student > Doctoral Student | 94 | 8% |
Other | 220 | 18% |
Unknown | 239 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 305 | 25% |
Biochemistry, Genetics and Molecular Biology | 215 | 18% |
Agricultural and Biological Sciences | 186 | 15% |
Neuroscience | 65 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 34 | 3% |
Other | 137 | 11% |
Unknown | 286 | 23% |